NCT06312527 is a NA clinical trial of Silicone dressing in Scar Prevention, sponsored by Thammasat University Hospital.

Who is sponsoring NCT06312527?

NCT06312527 is sponsored by Thammasat University Hospital.

What drugs are being tested in NCT06312527?

Interventions in NCT06312527: Silicone dressing.

What condition does NCT06312527 study?

NCT06312527 studies Scar Prevention.

Is NCT06312527 still recruiting?

NCT06312527 is currently active, enrolled. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT06312527

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mepiform in Simultaneous Bilateral TKA

Active, enrolled NA Last updated 9 April 2025

What this trial tests

NA trial testing Silicone dressing in Scar Prevention in 30 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

7 March 2024

Primary endpoint
31 May 2024

31 May 2025

Quick facts

Lead sponsor	Thammasat University Hospital
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	7 March 2024
Primary completion	31 May 2024
Estimated completion	31 May 2025
Sites	1 location across Thailand

Drugs / interventions tested

Silicone dressing

Conditions studied

Scar Prevention — all drugs for Scar Prevention →

Sponsor

Thammasat University Hospital

Who can join

Adults 50 to 80, any sex, with Scar Prevention. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this RCT is comparing efficacy of silicone dressing in scar preventing after simultaneous bilateral total knee arthroplasty. The main question\[s\] it aims to answer are: * Does silicone dressing can prevent scar formation after total knee arthroplasty? * Does silicone dressing have similar functional outcomes and complications after total knee arthroplasty? Participants will apply silicone dressing after wound healed and apply for 10 weeks. Researchers will compare to the other side that is no intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Thammasat University Hospital trials

Trials by the same sponsor.

NCT06910930 — Impact of Muscle Training Device on Non-Severe OSA · NA · recruiting
NCT06943053 — Evaluation of Ioband Coverage Waterproof Dressing Versus Isolated Waterproof Dressing After Primary Total Knee Arthropla · NA · recruiting
NCT06800846 — Comparative Analgesic Effect After Total Knee Arthroplasty Between Intraosseous and Peri-articular Injection · Phase 4 · enrolling by invitation
NCT06328062 — Comparing Efficiency of Mirogabalin and Pregabalin in Primary TKA · NA · recruiting
NCT06323577 — Comparing Efficacy Between Restricted Kinematic Alignment vs Mechanical Alignment in Bilateral TKA · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06312527 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Thammasat University Hospital
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06312527.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing